In vitro expansion of Wilms’ tumor protein 1 epitope-specific primary T cells from healthy human peripheral blood mononuclear cells
Source
STAR Protocols - ISSN 2666-1667-4:1 (2023) p. 1-18
Het Wilms'tumor 1 (WT1) eiwit als target voor gepersonaliseerde immuuntherapie bij kanker
Source
Oncotherapie-5:3 (2020) p. 25-26
Ribonucleic Acid Engineering of Dendritic Cells for Therapeutic Vaccination: Ready 'N Able to Improve Clinical Outcome?
Source
CANCERS-12:2 (2020) p.
Optimizing dendritic cells for cancer vaccination through introduction of ribonucleic acid for neo-expression of the tumor-associated antigen "receptor for hyaluronic acid-mediated motility" and the cytokine interferon-α
Source
Antwerp, Faculty of Medicine and Health Sciences, 2019,130 p.
Poly(I:C) primes primary human glioblastoma cells for an immune response invigorated by PD-L1 blockade
Source
Oncoimmunology - ISSN 2162-402X-7:3 (2018) p.